AKT-4014
Which of the following anti-epileptic medications poses the highest risk of neurodevelopmental delay when taken by expectant mothers?
Archives: MRCGP AKT
AKT-4015
What is the accuracy of using the combined oral contraceptive pill in women?
AKT-4016
Which one of the following drugs is safe for lactating mothers to use?
AKT-4017
A 25-year-old woman comes in seeking to switch from her current Microgynon 30 COC to another option due to experiencing mood swings. The decision is made to start her on Marvelon. What guidance should be provided regarding transitioning to a new COC?
AKT-4018
A 22-year-old woman comes to the clinic seeking advice on delaying her menstrual cycle for a week during her upcoming travels. She doesn’t smoke, has no risk factors for venous thromboembolism, and has no history of heart disease or breast cancer. She is currently using only barrier contraception.
What would be the most suitable course of action for management?
AKT-4019
A 25-year-old woman had blood tests taken at her 12-week booking appointment with the midwife. This is her first pregnancy and she has no significant medical history. The results of her full blood count (FBC) are as follows:
– Hb: 110 g/L
– Platelets: 340 10^9/L
– WBC: 7.2 10^9/L
What would be the most appropriate course of action based on these findings?
AKT-4001
You encounter a 24-year-old nulliparous woman who wishes to discuss contraception. She has tried various pills over the past few years but has not found one that suits her.
During your discussion of the available options, she expresses a preference for an intrauterine system (IUS) over a copper intrauterine device (IUD) due to concerns about heavier or more painful periods. You provide information on the Mirena®, Jaydess®, and newer Kyleena® IUS options, but she is uncertain which one to choose.
What advice should you offer her?
AKT-4002
You see a 26-year-old patient who is wondering about the duration of her Kyleena® coil for contraception. She currently has the 19.5mg levonorgestrel (LNG) IUS which was inserted 20 months ago.
What is the licensed duration of the Kyleena® coil for contraception in this patient’s case?
AKT-4003
A 28-year-old woman who is 10 weeks postpartum seeks advice. She had unprotected sex with her partner two nights ago. She is currently breastfeeding her baby and her partner gives a formula feed at night. She has not had any periods since giving birth and is concerned about the possibility of becoming pregnant again, which she considers not an option at the moment. The incident of unprotected sex occurred approximately 50 hours ago, and she is not open to considering an intrauterine device. What is the best course of action in this situation?
AKT-4004
A 50-year-old woman visits the clinic with inquiries about her Mirena coil. The coil was implanted 4 years ago to treat dysfunctional uterine bleeding. She has not had any menstrual periods for 3 years and is uncertain if it should be taken out. She is currently on elleste solo 1 mg to alleviate menopausal symptoms and was informed that the Mirena was a component of her hormone replacement therapy. What is the duration of the Mirena coil’s license for this purpose?